“A federal judge in Texas issued a preliminary ruling invalidating the Food and Drug Administration’s 23-year-old approval of the abortion pill mifepristone, an unprecedented order that — if it stands through court challenges — could make it harder for patients to get abortions in states where abortion is legal, not just in those trying to restrict it,” the Wall Street Journal reports.
“The drug will continue to be available at least in the short-term because the judge, Matthew Kacsmaryk, stayed his own order for seven days to give the F.D.A. time to ask an appeals court to intervene.”
Save to Favorites